Study links protein to MDS survival rate, progression to AML

10/6/2011 | MDSBeacon.com

Taiwanese researchers have discovered that people with myelodysplastic syndromes who have lower levels of the angiopoietin-1 protein were less likely to progress to acute myeloid leukemia and survived longer compared with patients who had higher levels of the protein. The protein plays a role in the formation of new blood vessels, according to the study published in the British Journal of Cancer.

View Full Article in:

MDSBeacon.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL